A Study to Assess Benign Joint Hypermobility Syndrome in Children With a History of Wheezing or Asthma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

23 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess benign joint hypermobility syndrome (BJHS) in children with a history of wheezing or asthma. BJHS is a common syndrome of joint and connective tissue laxity without any other rheumatologic disease. This assessment will be performed by using either method below depending upon if the child has a history of wheezing or severe asthma:

1. Determine the correlation, if there is an increased rate of BJHS in children with a history of wheezing as well as if there is an increased history of wheezing in children with BJHS; or
2. Determine asthma control, lung function and asthma exacerbations (a flare up or acute worsening of symptoms) in children with BJHS compared to children with asthma without BJHS, to assess if it BJHS is associated more with children with severe asthma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pulmonary MRI of Ex-preterm Children With and Without BPD To Understand Risk of Emphysematous Changes

NCT02921308

Bronchopulmonary Dysplasia

COMPLETED

Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital

NCT07173010

Mucopolysaccharidoses Progressive Pseudorheumatoid Dysplasia Farber Disease +3 more

NOT_YET_RECRUITING

Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia

NCT02652533

Biliary Atresia

COMPLETED

Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA

NCT00792233

Juvenile Idiopathic Arthritis

COMPLETED PHASE4

SPAIN Chest Wall Deformity Project (Pectus Repair)

NCT02098681

Deformity of Chest Wall

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Joint Hypermobility Syndrome Wheezing Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

History of Wheezing, Benign Joint Hypermobility Syndrome

No interventions assigned to this group

Asthma, Benign Joint Hypermobility Syndrome

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All children ages 6-16 with a history of wheezing or asthma

Exclusion Criteria

* For subjects with a history of Wheezing: History of chronic lung disease or prematurity, chronic aspiration, congenital anomalies of the upper and lower airway, primary ciliary dyskinesia, cystic fibrosis, history of heart failure, immune deficiency, or any inflammatory arthritis.
* For Subjects with a history of Asthma: current acute respiratory exacerbation, history of chronic lung disease of prematurity, chronic aspiration, congenital anomalies of the upper or lower airway, primary ciliary dyskinesia, cystic fibrosis, restrictive lung disease, history of heart failure, immune deficiency, or inflammatory arthritis.

Minimum Eligible Age

6 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No